Evidence map›Paper›PMID 34257529›Full record

SynthesisPathology oncology research : POR2021

SP1 Expression and the Clinicopathological Features of Tumors: A Meta-Analysis and Bioinformatics Analysis.

Yue Gao, Kai Gan, Kuangzheng Liu, Bin Xu, Ming Chen

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Unraveling the role of specificity protein 1 in gliomas: pathophysiology and clinical implications.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  4. Review
  5. Potential ofFrontiers in immunology · 2026
    Article
  6. Article
  7. Function ofOncology letters · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Pan-cancer drivers of metastasis.Molecular cancer · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Specificity Proteins (Sp) and Cancer.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yue GaoSurgical Research Center, Institute of Urology, Medical School of Southeast University Nanjing, Jiangsu, China.
Kai GanSurgical Research Center, Institute of Urology, Medical School of Southeast University Nanjing, Jiangsu, China.
Kuangzheng LiuSurgical Research Center, Institute of Urology, Medical School of Southeast University Nanjing, Jiangsu, China.
Bin XuDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, China.
Ming ChenDepartment of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, Jiangsu, China.
Southeast University · CNZhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorComputational BiologyFemaleHumansLymphatic MetastasisMaleNeoplasm InvasivenessNeoplasmsNeoplasm StagingPrognosisSp1 Transcription FactorSurvival AnalysisBiomarkers, TumorSP1 protein, humanSp1 Transcription Factorbiomarkercancerclinicopathological characteristicsprognosisspecificity protein 1

Identifiers

PMID34257529
PMCPMC8262197
OpenAlexW3127800366

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.